| Financier | Commitments |
|---|---|
| IDA Credit | 67.00 |
| Trust Funds | 15.00 |
| IDA Grant | 87.00 |
Senegal COVID-19 Response Project
Abstract*
The Senegal COVID-19 Response Project (P173838) was initiated to prevent, detect, and respond to the COVID-19 pandemic while strengthening Senegal's national public health preparedness. Approved on April 2, 2020, and made effective on April 6, 2020, the project will close on December 31, 2025. Two rounds of Additional Financing (AF) have expanded the project’s scope. The first, approved in 2021, increased the project’s funding by USD 134 million to... Show More
Development Objective
The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Senegal
Key Details
Project Details
P173838
Active
Laurence Lannes , Aida Gadiaga
Ministry of Finances and Budget
March 26, 2020
(as of board presentation)
April 2, 2020
April 6, 2020
US$ 20.00 million
Ministry of Health and Social Action
2020
US$ 169.00 million
N/A
April 8, 2024
December 31, 2025
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 154.00 |
| IBRD + IDA Commitment | 154.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | 15.00 |
| Total Project Cost** | 20.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Oct 5, 2023 | IDA-69640 | Loan Disb | 45,236.30 |
| Nov 14, 2023 | IDA-69640 | Loan Disb | 745,941.06 |
| Apr 25, 2024 | IDA-69640 | Int Charges | 104,669.03 |
| Apr 25, 2024 | IDA-69640 | Int Charges | 104,669.03 |
| Apr 25, 2024 | IDA-69640 | Int Charges | 136.72 |
| Apr 25, 2024 | IDA-69640 | Int Charges | 136.72 |
| Apr 19, 2024 | IDA-69640 | Loan Disb | 173,063.34 |
| Jul 13, 2023 | IDA-69640 | Loan Disb | 14,019.34 |
| Oct 15, 2023 | IDA-65990 | Int Charges | 12,030.92 |
| Oct 15, 2023 | IDA-65990 | Int Charges | 12,030.92 |
| Jun 5, 2023 | IDA-69640 | Loan Disb | 27,517.46 |
| Jun 8, 2023 | IDA-69640 | Loan Disb | 203,833.16 |
| Apr 15, 2023 | IDA-69640 | Int Charges | 264.56 |
| Apr 15, 2023 | IDA-69640 | Int Charges | 264.56 |
| Apr 15, 2023 | IDA-69640 | Int Charges | 34,668.05 |
| Apr 15, 2023 | IDA-69640 | Int Charges | 34,668.05 |
| Apr 15, 2023 | IDA-65990 | Int Charges | 75,470.55 |
| Apr 15, 2023 | IDA-65990 | Int Charges | 75,470.55 |
| Apr 13, 2023 | IDA-69640 | Loan Disb | 71,101.85 |
| Apr 15, 2023 | IDA-69640 | Int Charges | 43,877.11 |
| Apr 15, 2023 | IDA-69640 | Int Charges | 43,877.11 |
| Dec 7, 2022 | IDA-69640 | Loan Disb | 66,423.74 |
| Sep 5, 2023 | IDA-69640 | Loan Disb | 23,875.16 |
| May 8, 2023 | IDA-69640 | Loan Disb | 5,562,614.50 |
| Jan 23, 2023 | IDA-69640 | Loan Disb | 433,466.75 |
| Oct 15, 2021 | IDA-65990 | Int Charges | 710.98 |
| Oct 15, 2021 | IDA-65990 | Int Charges | 710.98 |
| Oct 15, 2021 | IDA-65990 | Int Charges | 74,799.96 |
| Oct 15, 2021 | IDA-65990 | Int Charges | 74,799.96 |
| Mar 25, 2021 | IDA-65990 | Loan Disb | 4,277.46 |
| Jul 2, 2021 | IDA-65990 | Loan Disb | 1,213,413.80 |
| Apr 26, 2021 | IDA-65990 | Loan Disb | 41,480.37 |
| Apr 15, 2021 | IDA-65990 | Int Charges | 56,340.10 |
| Apr 15, 2021 | IDA-65990 | Int Charges | 56,340.10 |
| Apr 21, 2020 | IDA-65990 | Loan Disb | 2,311,965.50 |
| May 13, 2020 | IDA-65990 | Loan Disb | 842,602.44 |
| May 29, 2020 | IDA-65990 | Loan Disb | 1,495,823.90 |
| Jun 17, 2020 | IDA-65990 | Loan Disb | 684,847.20 |
| May 18, 2020 | IDA-65990 | Loan Disb | 972,825.44 |
| May 15, 2020 | IDA-65990 | Loan Disb | 838,221.56 |
| Jun 11, 2020 | IDA-65990 | Loan Disb | 813,263.94 |
| Nov 2, 2020 | IDA-65990 | Loan Disb | 183,174.77 |
| Nov 2, 2020 | IDA-65990 | Loan Disb | 152,474.84 |
| Oct 16, 2020 | IDA-65990 | Int Charges | 30,020.93 |
| Oct 16, 2020 | IDA-65990 | Int Charges | 30,020.93 |
| Jun 16, 2021 | IDA-65990 | Loan Disb | 665,035.44 |
| Dec 18, 2020 | IDA-65990 | Loan Disb | 1,647,146.50 |
| Nov 24, 2020 | IDA-65990 | Loan Disb | 1,601,693.40 |
| Nov 12, 2020 | IDA-65990 | Loan Disb | 1,373,891.80 |
| Oct 5, 2022 | IDA-69640 | Loan Disb | 371,572.25 |
| Dec 7, 2022 | IDA-69640 | Loan Disb | 57,736.57 |
| Dec 8, 2022 | IDA-69640 | Loan Disb | 462,887.53 |
| Oct 7, 2022 | IDA-69640 | Loan Disb | 43,317.97 |
| Nov 4, 2022 | IDA-69640 | Loan Disb | 41,643.39 |
| Nov 4, 2022 | IDA-69640 | Loan Disb | 66,963.08 |
| Oct 15, 2022 | IDA-69640 | Int Charges | 49,185.11 |
| Oct 15, 2022 | IDA-69640 | Int Charges | 49,185.11 |
| Apr 27, 2022 | IDA-65990 | Loan Disb | 3,841.52 |
| Apr 27, 2022 | IDA-65990 | Loan Disb | 3,841.53 |
| Oct 12, 2022 | IDA-69640 | Loan Disb | 1,521,374.60 |
| Oct 12, 2022 | IDA-69640 | Loan Disb | 18,381.56 |
| Oct 12, 2022 | IDA-69640 | Loan Disb | 215,946.67 |
| Oct 12, 2022 | IDA-69640 | Loan Disb | 636,126.60 |
| Oct 18, 2022 | IDA-69640 | Loan Disb | 159,964.90 |
| Oct 15, 2021 | IDA-65990 | Loan Disb | 119,130.09 |
| Oct 13, 2021 | IDA-69640 | Loan Disb | 5,001,649.00 |
| Sep 24, 2021 | IDA-69640 | Loan Disb | 10,733,935.00 |
| Apr 15, 2022 | IDA-69640 | Int Charges | 4,520.38 |
| Apr 15, 2022 | IDA-69640 | Int Charges | 4,520.38 |
| Apr 15, 2022 | IDA-69640 | Int Charges | 54,611.39 |
| Apr 15, 2022 | IDA-69640 | Int Charges | 54,611.39 |
| May 16, 2022 | IDA-65990 | Loan Disb | 3,400.66 |
| Apr 15, 2022 | IDA-65990 | Int Charges | 108.09 |
| Apr 15, 2022 | IDA-65990 | Int Charges | 108.09 |
| Apr 15, 2022 | IDA-65990 | Int Charges | 73,617.12 |
| Apr 15, 2022 | IDA-65990 | Int Charges | 73,617.12 |
| Sep 21, 2020 | IDA-65990 | Loan Disb | 167,916.44 |
| Jul 31, 2020 | IDA-65990 | Loan Disb | 969,327.50 |
| Oct 18, 2022 | IDA-69640 | Loan Disb | 710,150.70 |
| Oct 15, 2022 | IDA-65990 | Int Charges | 97.35 |
| Oct 15, 2022 | IDA-65990 | Int Charges | 97.35 |
| Oct 15, 2022 | IDA-65990 | Int Charges | 66,434.29 |
| Oct 15, 2022 | IDA-65990 | Int Charges | 66,434.29 |
| Dec 21, 2022 | IDA-69640 | Loan Disb | 1,741,835.60 |
| Jan 25, 2024 | IDA-69640 | Loan Disb | 93,161.27 |
| Jun 6, 2024 | IDA-69640 | Loan Disb | 249,059.80 |
| Jul 22, 2024 | IDA-69640 | Loan Disb | 342,919.78 |
| Apr 26, 2024 | IDA-65990 | Int Charges | 73,215.00 |
| Apr 26, 2024 | IDA-65990 | Int Charges | 73,215.00 |
| Jul 22, 2024 | IDA-69640 | Loan Disb | 108,194.79 |
| May 3, 2024 | IDA-69640 | Loan Disb | 432,499.12 |
| Nov 30, 2023 | IDA-69640 | Loan Disb | 87,629.93 |
| Oct 15, 2023 | IDA-69640 | Int Charges | 2.83 |
| Oct 15, 2023 | IDA-69640 | Int Charges | 2.83 |
| Oct 15, 2023 | IDA-69640 | Int Charges | 96,785.94 |
| Oct 15, 2023 | IDA-69640 | Int Charges | 96,785.94 |
| Oct 15, 2023 | IDA-65990 | Int Charges | 59,750.90 |
| Oct 15, 2023 | IDA-65990 | Int Charges | 59,750.90 |
| Dec 27, 2021 | IDA-D8890 | Loan Disb | 1,178,335.20 |
| Dec 15, 2021 | IDA-D8890 | Loan Disb | 2,037,785.60 |
| Dec 15, 2021 | IDA-D8890 | Loan Disb | 2,204,496.00 |
| Dec 15, 2021 | IDA-D8890 | Loan Disb | 456,782.34 |
| Dec 15, 2021 | IDA-D8890 | Loan Disb | 16,803,360.00 |
| Jun 2, 2021 | IDA-69640 | Loan Commitment | 67,000,000.00 |
| Jun 2, 2021 | IDA-D8890 | Loan Commitment | 67,000,000.00 |
| Apr 2, 2020 | IDA-65990 | Loan Commitment | 20,000,000.00 |
| Jan 5, 2024 | IDA-D8890 | Loan Disb | -16,803,360.00 |
| Jul 31, 2020 | IDA-65990 | Loan Disb | 1,378,418.80 |
| Apr 15, 2021 | IDA-65990 | Int Charges | 85.21 |
| Apr 15, 2021 | IDA-65990 | Int Charges | 85.21 |
| Apr 7, 2021 | IDA-65990 | Loan Disb | 487,375.50 |
| Apr 7, 2021 | IDA-65990 | Loan Disb | 910,312.70 |
| May 21, 2021 | IDA-65990 | Loan Disb | 670,603.06 |
| Jun 8, 2021 | IDA-65990 | Loan Disb | 596,601.70 |
| Mar 18, 2021 | IDA-65990 | Loan Disb | 84,537.20 |
| Mar 18, 2021 | IDA-65990 | Loan Disb | 4,322.90 |
| Mar 18, 2021 | IDA-65990 | Loan Disb | 354,979.28 |
| Mar 18, 2021 | IDA-65990 | Loan Disb | 436,862.30 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Procurement | Moderately Satisfactory | 2024-12-06 |
| Project Management | Moderately Unsatisfactory | 2024-12-06 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-12-06 |
| Financial Management | Moderately Satisfactory | 2024-12-06 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-12-06 |
| Overall Implementation Progress (IP) | Moderately Unsatisfactory | 2024-12-06 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Suspected cases of COVID-19 cases reported and investigated per approved protocol Value 0.00 1028260.00 600000.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Suspected cases that test positive Value 0.00 88955.00 50000.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Health staff trained in COVID-19 prevention, testing and care per MoHSA-approved protocols Value 1518.00 6610.00 2500.00 Date November 17, 2020 February 27, 2024 December 31, 2025 Comment District health centers/hospitals with personal protective equipment and infection control products and supplies Value 0.00 84.00 90.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Percentage of population vaccinated Value 0.00 17.00 55.00 Date February 1, 2021 February 27, 2024 December 31, 2025 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan Value 0.00 4.77 20.00 Date February 1, 2021 February 27, 2024 December 31, 2025 Comment Females vaccinated Value 0.00 51.44 40.00 Date February 1, 2021 February 27, 2024 December 31, 2025 Comment Female healthcare workers vaccinated Value 0.00 54.41 60.00 Date February 1, 2021 February 27, 2024 December 31, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Community actors trained Value 0.00 0.00 500.00 Date May 1, 2023 February 27, 2024 December 31, 2025 Comment Number of healthcare facilities and warehouses provided with climate-sensitive/energy-efficient cold chain equipment to store COVID-19 vaccines Value 0.00 2.00 50.00 Date February 15, 2021 February 27, 2024 December 31, 2025 Comment TV, radio and social media spots produced on COVID-19 Value 0.00 300.00 400.00 Date February 15, 2021 February 27, 2024 December 31, 2025 Comment Number of national, sub-national, facility-based and mobile staff trained in COVID-19 vaccine cold chain, storage and handling Value 0.00 0.00 300.00 Date February 15, 2021 February 27, 2024 December 31, 2025 Comment Healthcare workers and community-based nurses trained on GBV/SEA/SH Value 0.00 12.00 300.00 Date April 1, 2021 February 27, 2024 December 31, 2025 Comment Pharmacovigilance System (PVS) adapted to detect Adverse Events Following Vaccination (AEFI) for the COVID-19 vaccine Value No Yes Yes Date February 15, 2021 February 27, 2024 December 31, 2021 Comment Number of AEFI cases reported Value 0.00 134.00 100.00 Date February 23, 2021 February 27, 2024 December 31, 2025 Comment Women having 4 antenatal care visits (ANCs) Value 65.00 0.00 83.00 Date December 31, 2022 February 27, 2024 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services Value 8085860.00 0.00 8817975.00 Date December 31, 2022 February 27, 2024 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement) Value 0.00 0.00 0.00 Date Comment Number of children immunized Value 125137.00 0.00 275137.00 Date December 31, 2022 February 27, 2024 December 31, 2025 Comment Number of women and children who have received basic nutrition services Value 0.00 0.00 245229.00 Date April 4, 2023 February 27, 2024 December 31, 2025 Comment Number of deliveries attended by skilled health personnel Value 263114.00 0.00 600000.00 Date December 31, 2022 February 27, 2024 December 31, 2025 Comment Contraceptive prevalence rate Value 25.50 0.00 36.00 Date December 31, 2022 February 27, 2024 December 31, 2025 Comment Health facilities reporting no stock-out of tracer essential medicines and products, including COVID-19 vaccincations, at the time of the health facility supervision visit Value 0.00 0.00 80.00 Date April 4, 2023 February 27, 2024 December 31, 2025 Comment Health personnel trained Value 0.00 0.00 2000.00 Date May 1, 2023 February 27, 2024 December 31, 2025 Comment Females Value 0.00 0.00 1000.00 Date June 1, 2023 February 27, 2024 December 31, 2025 Comment Continuous Value 0.00 0.00 1900.00 Date May 1, 2023 February 27, 2024 December 31, 2025 Comment Healthcare workers and community-based nurses trained on COVID-19 prevention, control and contact tracing Value 0.00 6335.00 2000.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Assessment conducted to identify behavioral and socio-cultural risk factors for COVID-19 covering all the regions Value No Yes Yes Date March 19, 2020 February 27, 2024 June 30, 2021 Comment Establishment of joint M&E systems supporting the One Health approach and epidemic preparedness and response Value No Yes Yes Date March 19, 2020 February 27, 2024 June 30, 2021 Comment People reached through hygiene promotion activities Value 0.00 540.00 1000.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Meetings held by the platform Value 0.00 92.00 125.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Healthcare facilities that received protective equipment and hygiene materials Value 0.00 116.00 119.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Community health workers trained on community-based disease surveillance Value 0.00 0.00 2000.00 Date September 18, 2023 February 27, 2024 December 31, 2025 Comment Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents per MOHSA guidelines Value 0.00 9.00 7.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Implementation of the third and fourth phases of the rapid surveillance system for the continuity of EHS Value No No Yes Date April 4, 2023 February 27, 2024 December 31, 2025 Comment Patients that are satisfied with the treatment of COVID-19 received Value 0.00 71.53 70.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Point of entry/ border officers trained on COVID-19 prevention, control and contact tracing Value 0.00 901.00 160.00 Date March 19, 2020 February 27, 2024 December 31, 2021 Comment Social Distancing communication strategy developed Value No Yes Yes Date March 19, 2020 February 27, 2024 July 31, 2020 Comment Health centers/hospitals received supervision for COVID-19 Value 0.00 99.00 80.00 Date March 19, 2020 February 27, 2024 December 31, 2025 Comment Long-term Value 0.00 0.00 100.00 Date May 1, 2023 February 27, 2024 December 31, 2025 Comment